Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Gynecology

Testing and Pathology: The Road to a Diagnosis

At a Glance

Chronic cervicitis is evaluated with a pelvic exam and targeted tests for infections such as chlamydia, gonorrhea, trichomonas, and sometimes Mycoplasma genitalium. Persistent bleeding, high-risk HPV, or abnormal findings may require colposcopy and biopsy.

The process of diagnosing chronic cervicitis involves a step-by-step investigation to find the source of inflammation and rule out more serious cell changes. Because symptoms like discharge or bleeding can be caused by many different things, your doctor will use a combination of physical exams, laboratory tests, and clinical judgment [1][2].

The Clinical Examination

Your evaluation almost always begins with a pelvic examination. This is more than just a visual check; it is a diagnostic tool to see how the tissue is reacting and whether the inflammation has spread [3].

  • Speculum Exam: Your doctor will look for mucopurulent discharge (thick yellow or green fluid) and check for cervical friability, which is when the cervix bleeds easily upon being touched with a cotton swab [4][5].
  • Bimanual Exam: The doctor will gently press on your abdomen while moving the cervix with their fingers. They are checking for cervical motion tenderness, uterine tenderness, or adnexal (ovary) tenderness [5]. If any of these are present, it may suggest the inflammation is not just on the cervix but has developed into Pelvic Inflammatory Disease (PID) [3][6]. PID is a clinical judgment, and doctors often have a low threshold for treating it if these signs are present in the right context.

Essential Laboratory Tests

Modern testing relies heavily on NAAT (Nucleic Acid Amplification Test), a highly sensitive test that can detect a pathogen’s nucleic acid [7]. There is no universal “standard STI panel”—testing is individualized based on your symptoms and risks.

  • Common Targets: You will likely be tested for Chlamydia trachomatis and Neisseria gonorrhoeae [8][9]. Depending on risk and the specific lab, Trichomonas vaginalis may also be included.
  • Vaginal Environment Checks: A wet mount (looking at a sample under a microscope) or molecular tests may be used to check for Bacterial Vaginosis (BV) or yeast, which often coexist with cervicitis [10][9].
  • Persistent Symptoms: If symptoms return after treatment or routine tests are negative, your doctor may test for Mycoplasma genitalium [11][2]. This organism often requires different antibiotics than Chlamydia [9][12].
  • Other Screening: HIV and syphilis testing may be recommended as separate risk-based screening considerations.

When Advanced Testing is Needed

If your cervix looks highly irregular, if you have persistent unexplained bleeding, or if your routine screening shows high-risk HPV (Human Papillomavirus), your doctor will move to more detailed diagnostic steps [13][14].

  • Colposcopy: This is a procedure where the doctor uses a specialized magnifying lens (a colposcope) to look closely at the transformation zone—the area where most cervical changes begin [15][16]. They may apply a vinegar-like solution that turns abnormal cells white to help them see where to focus [17].
  • Biopsy: If suspicious areas are seen during a colposcopy, a small tissue sample (biopsy) will be taken [18]. This helps distinguish between simple chronic inflammation and precancerous conditions like CIN (Cervical Intraepithelial Neoplasia) [19][20].

Understanding Your Lab Report

When you receive your results, you may see terms that describe the state of your tissue rather than a specific disease:

Term on Report What it Means in Plain Language
Chronic Nonspecific Inflammation Inflammation was seen in that sample. It does not by itself rule out every infection or cancer, nor does it guarantee an active infection [21].
Squamous Metaplasia A normal process where cervical cells change from one type to another; it is not cancer [16].
Leukocyte Infiltrate White blood cells have moved into the tissue to fight an irritant or infection [22].
NILM “Negative for Intraepithelial Lesion or Malignancy”—meaning no precancer or cancer was found on that specific cytology specimen [23].

It is important to remember that a “chronic cervicitis” finding on a pathology report must be interpreted alongside your physical exam and recommended follow-up to ensure nothing is missed [20][19][13][24].

Comparison of Common Cervical and Vaginal Conditions

Condition Typical Findings Common Tests Primary Management
Cervicitis Abnormal discharge, post-coital bleeding, friable cervix. NAAT for Chlamydia, Gonorrhea, Trichomonas. Target the specific pathogen; empiric antibiotics if high risk.
Vaginitis / BV Vaginal odor, itching, or abnormal discharge without cervical bleeding. Wet mount, pH, molecular vaginal panel. Treat the symptomatic imbalance (e.g., Metronidazole).
Cervical Ectropion Mucus discharge, contact bleeding. Normal Pap/HPV. Visual exam, screening tests. Usually reassurance; cryotherapy only if severely bothersome.
PID Pelvic pain, fever, cervical motion tenderness. Clinical exam, STI testing, occasionally ultrasound. Immediate antibiotics to prevent upper-tract scarring.
Cervical Dysplasia Often asymptomatic. Detected on screening. Pap test, HPV test, Colposcopy, Biopsy. Monitor or treat precancerous cells based on severity.

Common questions in this guide

What tests are used to diagnose chronic cervicitis?
Chronic cervicitis is usually evaluated with a pelvic examination and tests tailored to your symptoms and risks. Molecular NAATs commonly check for chlamydia and gonorrhea, while testing for trichomonas, bacterial vaginosis, yeast, or Mycoplasma genitalium may be considered when appropriate.
What does chronic nonspecific inflammation mean on a cervical pathology report?
It means the tissue sample showed ongoing inflammation, but the phrase alone does not identify the cause. It does not prove that an infection is active or rule out every other condition, so your clinician should interpret it with your examination, infection tests, screening results, and recommended follow-up.
What does NILM mean on a cervical test?
NILM stands for negative for intraepithelial lesion or malignancy, meaning no precancer or cancer was found in that specific cytology sample. It may not explain discharge or bleeding, and it does not replace follow-up recommended based on your HPV result, symptoms, or examination.
When would chronic cervicitis require a colposcopy or biopsy?
Colposcopy may be recommended if the cervix looks irregular, bleeding persists without explanation, or high-risk HPV or screening results raise concern. A biopsy samples a suspicious area so a clinician can distinguish inflammation from precancerous changes such as cervical intraepithelial neoplasia.
Should I be tested for Mycoplasma genitalium if my symptoms continue?
Testing may be considered when symptoms return after treatment or routine tests are negative. This infection may require different antibiotic choices, so testing and treatment should be guided by a clinician.
Does chronic cervicitis mean I have cervical cancer?
No. Chronic cervicitis describes inflammation and is not itself a cancer diagnosis, although the finding alone may not rule out every other cause of bleeding or abnormal cells. Follow-up testing is important when the examination, HPV results, or pathology raises concern.
What symptoms could suggest that cervicitis has progressed to PID?
Cervical motion tenderness, uterine or adnexal tenderness, pelvic pain, and fever can raise concern for pelvic inflammatory disease, but diagnosis depends on the overall clinical picture. PID is treated promptly when suspected to reduce the risk of scarring in the upper reproductive tract.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.During my pelvic exam, did you notice any 'cervical motion tenderness' or pain in my uterus that might suggest Pelvic Inflammatory Disease (PID)?
  2. 2.Which specific pathogens was I tested for using the NAAT (molecular) method?
  3. 3.If my standard STI tests were negative, is it time to test for Mycoplasma genitalium or perform a vaginal 'wet mount' for bacterial vaginosis?
  4. 4.Does the 'chronic inflammation' on my pathology report require a follow-up colposcopy, or does my recent HPV test provide enough reassurance?
  5. 5.How does the appearance of my 'transformation zone' affect the accuracy of my recent biopsy or exam?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    No. 385-Indications for Pelvic Examination.

    Evans D, Goldstein S, Loewy A, Altman AD

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2019; (41(8)):1221-1234 doi:10.1016/j.jogc.2018.12.007.

    PMID: 31331610
  2. 2

    Clinical and Microbiological Profile of Recurrent and/or Persistent Cervicitis in Patients Attending Suraksha Clinic.

    Sahu A, Garg T, Kaur R, et al.

    Indian journal of dermatology 2026; (71(2)):169 doi:10.4103/ijd.ijd_658_24.

    PMID: 41884740
  3. 3

    Infectious Vaginitis, Cervicitis, and Pelvic Inflammatory Disease.

    Shroff S

    The Medical clinics of North America 2023; (107(2)):299-315 doi:10.1016/j.mcna.2022.10.009.

    PMID: 36759099
  4. 4

    Chronic Cervicitis: Presenting Features and Response to Therapy.

    Mattson SK, Polk JP, Nyirjesy P

    Journal of lower genital tract disease 2016; (20(3)):e30-3 doi:10.1097/LGT.0000000000000225.

    PMID: 27243142
  5. 5

    Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention.

    Curry A, Williams T, Penny ML

    American family physician 2019; (100(6)):357-364.

    PMID: 31524362
  6. 6

    Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways.

    Darville T

    The Journal of infectious diseases 2021; (224(12 Suppl 2)):S39-S46 doi:10.1093/infdis/jiab031.

    PMID: 34396413
  7. 7

    Evaluation of the performance of nucleic acid amplification tests (NAATs) in detection of chlamydia and gonorrhoea infection in vaginal specimens relative to patient infection status: a systematic review.

    Rönn MM, Mc Grath-Lone L, Davies B, et al.

    BMJ open 2019; (9(1)):e022510 doi:10.1136/bmjopen-2018-022510.

    PMID: 30659036
  8. 8

    Sexually Transmitted Infections Part 2: Discharge Syndromes and Pelvic Inflammatory Disease.

    Lemly D, Gupta N

    Pediatrics in review 2020; (41(10)):522-537 doi:10.1542/pir.2019-0078.

    PMID: 33004664
  9. 9

    Trends in infections detected in women with cervicitis over a decade.

    Vodstrcil LA, Plummer EL, Nguyen TV, et al.

    Frontiers in reproductive health 2025; (7()):1539186 doi:10.3389/frph.2025.1539186.

    PMID: 39963379
  10. 10

    Diagnostic Value of Vaginal Discharge, Wet Mount and Vaginal pH - An Update on the Basics of Gynecologic Infectiology.

    Frobenius W, Bogdan C

    Geburtshilfe und Frauenheilkunde 2015; (75(4)):355-366 doi:10.1055/s-0035-1545909.

    PMID: 26028693
  11. 11

    Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis.

    Lis R, Rowhani-Rahbar A, Manhart LE

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; (61(3)):418-26 doi:10.1093/cid/civ312.

    PMID: 25900174
  12. 12

    Management of non-gonococcal urethritis.

    Moi H, Blee K, Horner PJ

    BMC infectious diseases 2015; (15()):294 doi:10.1186/s12879-015-1043-4.

    PMID: 26220178
  13. 13

    Colposcopic Evaluation of Premalignant Lesions of the Cervix and Its Comparison With Liquid-Based Cytology.

    Bano K, Kumari K, Mishra P, et al.

    Cureus 2026; (18(7)):e112303 doi:10.7759/cureus.112303.

    PMID: 42571129
  14. 14

    European consensus statement on expert colposcopy.

    McGee AE, Alibegashvili T, Elfgren K, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2023; (290()):27-37 doi:10.1016/j.ejogrb.2023.08.369.

    PMID: 37716200
  15. 15

    Cervical Colposcopy: Indications and Risk Assessment.

    Burness JV, Schroeder JM, Warren JB

    American family physician 2020; (102(1)):39-48.

    PMID: 32603071
  16. 16

    Detection of High-Risk Human Papillomaviruses in the Prevention of Cervical Cancer in India.

    Baskaran K, Kumar PK, Karunanithi S, et al.

    Asian Pacific journal of cancer prevention : APJCP 2015; (16(18)):8187-90 doi:10.7314/apjcp.2015.16.18.8187.

    PMID: 26745058
  17. 17

    Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis.

    Silver MI, Andrews J, Cooper CK, et al.

    Obstetrics and gynecology 2018; (132(3)):725-735 doi:10.1097/AOG.0000000000002812.

    PMID: 30095780
  18. 18

    ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice.

    Wentzensen N, Schiffman M, Silver MI, et al.

    Journal of lower genital tract disease 2017; (21(4)):230-234 doi:10.1097/LGT.0000000000000334.

    PMID: 28953111
  19. 19

    Diagnostic value of colposcopy in patients with cytology-negative and HR-HPV-positive cervical lesions.

    Liu Y, Liao J, Yi X, et al.

    Archives of gynecology and obstetrics 2022; (306(4)):1161-1169 doi:10.1007/s00404-022-06415-5.

    PMID: 35320389
  20. 20

    Severe cervical inflammation and high-grade squamous intraepithelial lesions: a cross-sectional study.

    Long T, Long L, Chen Y, et al.

    Archives of gynecology and obstetrics 2021; (303(2)):547-556 doi:10.1007/s00404-020-05804-y.

    PMID: 32980959
  21. 21

    Cervicitis: How Often Is It Non-specific!

    Jayakumar NK

    Journal of clinical and diagnostic research : JCDR 2015; (9(3)):EC11-2 doi:10.7860/JCDR/2015/11594.5673.

    PMID: 25954624
  22. 22

    Local and systemic immunomodulatory mechanisms triggered by Human Papillomavirus transformed cells: a potential role for G-CSF and neutrophils.

    Alvarez KLF, Beldi M, Sarmanho F, et al.

    Scientific reports 2017; (7(1)):9002 doi:10.1038/s41598-017-09079-3.

    PMID: 28827632
  23. 23

    [The Clinical Significance of HPV L1/PD-L1 Tests Combined with Colposcopy for Cervical Precancerous Lesions and Cervical Cancer].

    Luo GP, Zeng X, Cao HY, et al.

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2021; (52(3)):516-522 doi:10.12182/20210560105.

    PMID: 34018374
  24. 24

    Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study.

    Dai W, Wang T, Chen L, et al.

    BMC women's health 2024; (24(1)):419 doi:10.1186/s12905-024-03258-x.

    PMID: 39049047

This page explains chronic cervicitis testing and pathology terms for informational purposes only and does not constitute medical advice. Your clinician should interpret your results and decide whether you need follow-up.

Get notified when new evidence is published on chronic cervicitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.